Terumo Syringe 2.5ml Luer Lock Syringe, Pack of 100

Product Information

Metaraminol should be used with caution in patients receiving digitalis, since the combination of digitalis and sympathomimetic amines is capable of causing ectopic arrhythmic activity. Regular human insulin products are considered 'fast-acting', with an onset of action around 30 minutes. High concentration regular human insulin (U500), have a slightly faster onset of action andduration of action. St John's Wort decreased plasma concentrations of midazolam by about 20-40% associated with a decrease in terminal half-life of about 15-17%. Depending on the specific St John's Wort extract, the CYP3A4-inducing effect may vary. If you are using syringes to draw up and inject your insulin, it is vitally important to be sure you are using the correct ones to prevent dosing errors. The Cleaning Concentrate in a 500 mL bottle offers an effective solution for maintaining instrument cleanliness and performance. It helps ensure accurate and reliable results by facilitating proper maintenance routines.

Hearst UK is the trading name of the National Magazine Company Ltd, 30 Panton Street, Leicester Square, London, SW1Y 4AJ. Registered in England. All Rights Reserved. Metaraminol, solution for injection in pre-filled syringe is contra-indicated in patients who are hypersensitive to the active ingredient or any of the excipients listed in section 6.1. A second or repeat dose when seizures re-occur after an initial response should not be given without prior medical advice (see section 5.2). The term 'units' refers to International Units (IU), which is a measure of the "biological activity" of a specificdrug or substance. International Units are used over a conventional metric measure (such as milligrams) to make it easier to compare different forms of the same drug. Essentially, the use of International Units is a way to standardize.

Simulated exposure data show that the overall AUC approximately doubles when a second dose is administered at 10, 30 and 60 minutes following the first dose. A second dose at 10 minutes results in a significant increase in mean C max of between 1.7 to 1.9-fold. At 30 and 60 minutes, significant elimination of midazolam has already occurred and therefore the increase in mean C max is less pronounced; 1.3 to 1.6 and 1.2 to 1.5-fold respectively (see section 4.2). Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme Metaraminol 0.5 mg/ml, solution for injection is already diluted and ready to use in pre-filled syringes. It should be used without prior dilution. Although all insulin products are considered 'equipotent' in regard to the fact that 1 unit of each equals 0.0347 mg, as described above, they have significant differences in their onset of action, time to peak effect, and duration of action.

Metaraminol, solution for injection in pre-filled syringe should not be used concurrently with cyclopropane or halothane anaesthesia, unless clinical circumstances demand it, due to a risk of serious venticular arrhythmia. The elimination half-life is longer in patients with congestive heart failure compared with that in healthy subjects (see section 4.4).If the medicine is an antibiotic make sure your child completes the prescribed course, even if your child seems better. There are no well-controlled studies in pregnant women. Metaraminol should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'. Co-administration with midazolam may cause enhanced sedation or respiratory and cardiovascular depression. In the management of overdose with any medicinal product, it should be borne in mind that multiple agents may have been taken.